Xiaoping Qian

4.4k total citations
124 papers, 2.9k citations indexed

About

Xiaoping Qian is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiaoping Qian has authored 124 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 38 papers in Oncology and 24 papers in Cancer Research. Recurrent topics in Xiaoping Qian's work include Nanoparticle-Based Drug Delivery (19 papers), Immunotherapy and Immune Responses (16 papers) and Genetic factors in colorectal cancer (15 papers). Xiaoping Qian is often cited by papers focused on Nanoparticle-Based Drug Delivery (19 papers), Immunotherapy and Immune Responses (16 papers) and Genetic factors in colorectal cancer (15 papers). Xiaoping Qian collaborates with scholars based in China, United States and Spain. Xiaoping Qian's co-authors include Baorui Liu, Rutian Li, Lixia Yu, Xiqun Jiang, Mi Yang, Jia Wei, Hanqing Qian, Jing Hu, Zhengyun Zou and Yue Lin and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Xiaoping Qian

117 papers receiving 2.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Xiaoping Qian 1.4k 797 710 559 395 124 2.9k
Lixia Yu 1.7k 1.2× 752 0.9× 859 1.2× 688 1.2× 613 1.6× 145 3.3k
Yongchuan Deng 914 0.6× 505 0.6× 498 0.7× 498 0.9× 427 1.1× 53 2.4k
Ruifang Niu 2.5k 1.8× 548 0.7× 969 1.4× 417 0.7× 972 2.5× 87 3.9k
Lei Yu 1.1k 0.8× 495 0.6× 982 1.4× 663 1.2× 240 0.6× 104 2.7k
Xiaodong Xie 1.7k 1.2× 375 0.5× 625 0.9× 506 0.9× 614 1.6× 141 3.2k
Ling Ding 2.2k 1.5× 507 0.6× 662 0.9× 589 1.1× 800 2.0× 135 4.2k
Ommoleila Molavi 1.3k 0.9× 541 0.7× 507 0.7× 373 0.7× 388 1.0× 73 2.7k
Xiang Gao 1.1k 0.8× 758 1.0× 453 0.6× 704 1.3× 176 0.4× 95 2.8k
Zhengdong Cai 1.4k 1.0× 243 0.3× 733 1.0× 508 0.9× 628 1.6× 91 2.9k
Mohammad Hojjat‐Farsangi 1.8k 1.2× 386 0.5× 1.1k 1.5× 432 0.8× 464 1.2× 139 4.0k

Countries citing papers authored by Xiaoping Qian

Since Specialization
Citations

This map shows the geographic impact of Xiaoping Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Qian more than expected).

Fields of papers citing papers by Xiaoping Qian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoping Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Qian. The network helps show where Xiaoping Qian may publish in the future.

Co-authorship network of co-authors of Xiaoping Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoping Qian. A scholar is included among the top collaborators of Xiaoping Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoping Qian. Xiaoping Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qian, Xiaoping, et al.. (2025). Recent advances in hydrogel-assisted treatment of malignant bone tumors. Materials Today Bio. 33. 102088–102088.
2.
3.
Li, Lin, Yueling Yang, Jie Shao, et al.. (2025). Verteporfin‐Mediated In Situ Nanovaccine Based on Local Conventional‐Dose Hypofractionated Radiotherapy Enhances Antitumor and Immunomodulatory Effect. Advanced Science. 12(20). e2413387–e2413387. 2 indexed citations
4.
5.
Zhou, Ying, et al.. (2025). EGFR influences the resistance to targeted therapy in BRAF V600E melanomas by regulating the ferroptosis process. Archives of Dermatological Research. 317(1). 514–514.
6.
Xu, Jing, et al.. (2024). Macrophage-derived VEGF-C reduces cardiac inflammation and prevents heart dysfunction in CVB3-induced viral myocarditis via remodeling cardiac lymphatic vessels. International Immunopharmacology. 143(Pt 1). 113377–113377. 6 indexed citations
7.
8.
Shen, Lin, Ningning Li, Weijian Guo, et al.. (2023). 1524P First-line TST001 plus capecitabine and oxaliplatin (CAPOX) for advanced G/GEJ cancer with CLDN18.2 positive overall survival data from study transtar102-Cohort C. Annals of Oncology. 34. S858–S859. 3 indexed citations
9.
Huang, Wei, et al.. (2023). An Analysis Regarding the Association Between Proteasome (PSM) and Hepatocellular Carcinoma (HCC). Journal of Hepatocellular Carcinoma. Volume 10. 497–515. 3 indexed citations
10.
Zhang, Qun, Jie Xiao, Xin Zhang, et al.. (2023). Cancer Cell Membrane-Coated Gambogic Acid Nanoparticles for Effective Anticancer Vaccination by Activating Dendritic Cells. International Journal of Nanomedicine. Volume 18. 2261–2273. 36 indexed citations
11.
Liu, Fangcen, Fangfang Zhong, Yao Fu, et al.. (2023). Prevalence and Associations of Beta2-Microglobulin Mutations in MSI-H/dMMR Cancers. The Oncologist. 28(3). e136–e144. 9 indexed citations
12.
Zhou, Ding, et al.. (2023). Membrane Trafficking-Related Genes Predict Tumor Immune Microenvironment and Prognosis in Colorectal Cancer. Biochemical Genetics. 62(2). 1413–1427. 2 indexed citations
13.
Zhang, Qun, Jing Hu, Yaping Zhang, et al.. (2022). Case report: A colorectal cancer patient with microsatellite instability-high and MSH2 germline mutation failed to respond to anti-PD-1 immunotherapy. Frontiers in Immunology. 13. 953421–953421. 1 indexed citations
14.
Shao, Jie, Qin Liu, Jie Shen, et al.. (2022). Advanced Pancreatic Cancer Patient Benefit From Personalized Neoantigen Nanovaccine Based Immunotherapy: A Case Report. Frontiers in Immunology. 13. 799026–799026. 9 indexed citations
15.
Li, Yiting, Xiaoping Qian, Xinghua Liu, et al.. (2020). Hydrophilic Polymer-Brush Functional Fluorescent Nanoparticles to Suppress Nonspecific Interactions and Enhance Quantum Yield for Targeted Cell Imaging. ACS Applied Polymer Materials. 2(6). 2238–2245. 6 indexed citations
16.
Yan, Jing, Ju Dong Yang, Wei Ren, et al.. (2018). Induction Chemotherapy with Paclitaxel Liposome, Nedaplatin, and Fluorouracil in Patients with Locally Advanced Nasopharyngeal Carcinoma: A Phase II Study. International Journal of Radiation Oncology*Biology*Physics. 102(3). e374–e375. 2 indexed citations
17.
Xu, Xi, Rong Jin, Ke Wang, et al.. (2014). Retention and tolerance of autoreactive CD4+ recent thymic emigrants in the liver. Journal of Autoimmunity. 56. 87–97. 8 indexed citations
18.
Guo, Xiaokai, Yuanfeng Liu, Yu Zhou, et al.. (2013). The Expression of Netrin-1 in the Thymus and Its Effects on Thymocyte Adhesion and Migration. SHILAP Revista de lepidopterología. 2013. 1–10. 3 indexed citations
19.
Qian, Xiaoping, Bo Yan, Xuefei Zhou, et al.. (2013). Synergistic Antiangiogenic Activity of Tetrandrine Combined with Endostar on the Human Umbilical Vein Endothelial Cell Model. Cancer Biotherapy and Radiopharmaceuticals. 28(5). 385–390. 9 indexed citations
20.
Qian, Xiaoping, et al.. (2004). [Effect of arsenic trioxide on drug transporting molecules in acute promyelocytic leukemia cell line].. PubMed. 26(10). 601–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lixia Yu Breakdown of academic impact, for papers by Yongchuan Deng Breakdown of academic impact, for papers by Ruifang Niu Breakdown of academic impact, for papers by Lei Yu Breakdown of academic impact, for papers by Xiaodong Xie Breakdown of academic impact, for papers by Ling Ding Breakdown of academic impact, for papers by Ommoleila Molavi Breakdown of academic impact, for papers by Xiang Gao Breakdown of academic impact, for papers by Zhengdong Cai Breakdown of academic impact, for papers by Mohammad Hojjat‐Farsangi
Rankless by CCL
2026